The European Commission has formally accused BMW, VW, and Daimler of colluding to impede the rollout of emissions limiting technology. These companies—whose car brands include Mercedes, Audi, Volkswagen, Porsche, and BMW—are said to have limited and delayed the use of tech that would have reduced the emissions of diesel and petrol cars.
Regulators accused the carmakers of colluding at their annual “circle of five” technical meetings, which are attended by BMW, Daimler, Volkswagen and its subsidiary brands Audi and Porsche.
The Commission claimed that one of the technologies affected by the scheme would have reduced harmful nitrogen oxide emissions from diesel cars.
The Statement of Objections issued Friday, April 5, comes a year and a half after EU authorities first raided the offices of the three companies over reports of possible collusion.
The EU’s Competition Commissioner, Margrethe Vestager, said that while collaboration to improve products is allowed, “EU competition rules do not allow [companies] to collude on exactly the opposite: not to improve their products, not to compete on quality.”
With this statement of objections now released, BMW, VW, and Daimler will have a chance to review the European Commission’s findings and respond to them before the authority comes to a final decision.
Full Content: CNN
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas